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Enhancement of “Quality of Life” As a Justification for Hand Transplantation: 
A Review and Critique of the Bioethics Literature After 20 Years of Experience 
Emily Ruppel Herrington, MA 
University of Pittsburgh, 2019 
 The initial and most widely referenced arguments for the ethical permissibility of hand 
transplantation (HTX) cite the bioethical principles of autonomy and beneficence to claim that, 
despite significant drawbacks of immunosuppression and surgery, HTX has the potential to 
enhance the lives of patients who fit appropriate criteria and are well-supported. However, the 
question of whether current cases of HTX can be described as having “enhanced life” has not been 
answered with attempts to assess patients’ experiences comprehensively (integrating quantitative, 
qualitative, and narrative research tools). This master’s thesis provides an overview of “quality-
of-life” oriented arguments in the literature on hand transplant ethics, focusing on how authors 
structure the permissibility of HTX in the absence of robust outcomes data, and criticizes this 
literature for its lack of empirical data reflecting HTX patients’ perspectives.  
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1.0 An Overview of “Quality of Life” Arguments in the Bioethical Discourse on Hand 
Transplantation 
 In the twenty years since the first published journal articles argued for the ethical and 
scientific viability of hand transplantation in the modern era of immunosuppression (Siegler, 1998; 
Simmons, 2000; Breidenbach, Tobin, Gorantla, Gonzales, and Grainger 2002), hand 
transplantation (HTX) and other forms of vascularized composite allotransplantation (VCA) have 
been seen to be possible (Kann, Furnas and Hewitt, 2000; Lanzetta et al., 2004; Gander et al., 
2006) and beneficial for properly selected and supported recipients (Schuind, Abramowicz and 
Schneeberger, 2007; Foroohar et al., 2011; Breidenbach et al., 2015; Cooney et al., 2018). 
Nevertheless, serious side effects of immunosuppressant medications have been experienced by 
patients (Hatrick and Tonkin, 2001; Hettiaratchy, Butler, and Lee, 2001; Baumeister et al., 2004; 
Boratynska et al., 2014; Kaminska et al., 2014), and new scientific techniques to minimize 
immunosuppression are not yet well understood with regard to their ability to improve the balance 
of risks and potential benefits of hand transplantation, the procedure’s risk:benefit ratio.  
Because HTX does not afford lifesaving or life-extending benefits, its permissibility 
resides in its potential to enhance patients’ subjective quality of life (QoL) for as long as they have 
their hand graft. Realizing these potential gains in QoL are complicated, however, by the 
vicissitudes of lifelong immunosuppression and the limitations to both QoL and, potentially, to 
longevity that immunosuppression presents. This master’s thesis argues that data describing and 
assessing patients’ own understanding of their experiences of HTX, as well as data regarding their 
pre- and post-operative QoL, should be systematically collected and then employed to inform 
arguments regarding hand transplantation in the HTX bioethics literature. By “bioethics literature” 
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I mean both commentary by bioethicists as well as papers co-authored by bioethicists and HTX 
clinician-researchers which have as their main topic traditionally “bioethical” issues including 
arguments about the permissibility of the practice, as well as arguments focused on processes of 
candidate evaluation, informed consent, and post-transplantation support for recipients and their 
informal caregivers. 
In this first section 1, I present a brief overview of the bioethical discourse on hand 
transplantation, paying special attention to the way patients’ quality of life before and after HTX 
has been imagined, characterized, and evaluated in these papers. This review reveals that first-
person data from patients’ own perspectives figure only minimally in these bioethical analyses, 
despite the fact that HTX was actually being performed experimentally around the world. Thus 
research illuminating ground-level insights from the HTX patient population was possible to carry 
out, if it had been prioritized by research teams.  In this thesis I argue that, in particular, the lived 
QoL tradeoffs in hand transplantation have not been adequately addressed in the HTX bioethics 
literature that instead relies on imagined QoL. I analyze several papers to support this observation. 
In section 2, I argue that HTX researchers and clinicians should make a priority of 
collecting and assessing first-person accounts from HTX patients. I suggest how analysis of such 
grounded accounts might address the challenge of representing QoL tradeoffs to HTX candidates 
more accurately during the candidate evaluation and informed consent processes. Systematic 
attempts to describe and assess patients’ experiences are needed to begin to answer the question 
of whether hand transplants adequately enhance life to justify continuation of the practice. It is 
not, I will show, an original idea that bioethical arguments need to take such qualitative data into 
account in their examination of the risk/benefit tradeoffs for evaluations of outcomes and ethicality 
of either research involving human subjects or clinical interventions. In the case of hand 
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transplantation, patient-participant perspectives are needed both to elucidate whether HTX is 
justified as a QoL-enhancing intervention and to better support decision-making by patient 
candidates and professionals in the field. I conclude section 2 with support from other areas of 
bioethics and person-centered healthcare/philosophy of medicine on the need for “commonsense” 
experiential understanding of the lived effects of HTX interventions, via robust integration of the 
advanced conceptual-analytical skillset of clinical bioethics with grounded qualitative research 
illuminating the lived/embodied knowledge of affected populations on their target area of concern 
(patient-participant quality of life). 
Making “quality of life” a goal of organ transplantation 
 Emergence of the notion that “quality of life” could be the goal of organ transplantation 
has been called “a quiet revolution in organ transplant ethics” by bioethics scholars (Caplan and 
Purves, 2017). The original and most widely referenced arguments for the ethical permissibility of 
hand transplantation cite the unique rehabilitative potential of these surgeries to claim that, despite 
significant drawbacks of immunosuppression and grueling aftercare, the risk/benefit balance of 
HTX can be positive for properly evaluated and supported patients (Siegler 1998; Dickenson and 
Hakim, 1999; Simmons, 2000; Breidenbach, Tobin, Gorantla, Gonzales, and Grainger 2002; Tobin 
et al., 2005). Mark Siegler, an ethicist who worked with one of the pioneering HTX research 
groups, describes how pre-experimental discussions of the ethics of hand transplantation circled 
the question of whether the improvement to quality of life from the patient’s perspective could 
balance the risks and burdens of chronic immunosuppression: 
After listening to papers discussing the laboratory and clinical background studies, 
the likely potential risks of the procedure, and also the potential benefits of the 
procedure, I concluded … that it was ethically acceptable to proceed with the trial. 
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In reaching this conclusion, I balanced the potential benefit of a successful 
cadaveric hand transplant … against the major likely risks of the procedure, risks 
which include the need for chronic immunosuppression and its consequences 
(1998, 2781). 
Two decades later, in 2019, science journalist David Dobbs considered the fundamentally 
subjective nature of risk/benefit tradeoffs in HTX for a WIRED article on U.S. hand transplant 
results. Dobbs describes the difficulty of balancing known risks with unknown benefits in hand 
transplantation where the goal is not to save, but to enhance, life: “Most people readily accept [the 
risks of immunosuppression] to get a new heart, lung, or liver … But a hand transplant sharply 
changes this calculus. Is taking dangerous drugs for the rest of one’s life worth the satisfaction of 
tying a shoelace or moving a strand of hair from a child’s face? Such deeply personal questions 
test the boundaries of medical ethics” (Dobbs, 2019, 44).  
Although skepticism as to the permissibility of HTX and VCA remained strong among 
some medical and ethical professionals throughout the field’s early years of human experiments, 
(Foucher, 1999; Hatrick and Tonkin, 2001; Manske, 2001; Meyer, 2001; Cooney and Hentz, 2002; 
Health Quality Ontario, 2016; Brugger et al., 2015; Hedges and Rosoff, 2018), outcomes reports 
on the first cases of VCA in the “modern” (post-cyclosporine) era of immunosuppression—two 
unilateral hand transplants in Lyon, France, and Louisville, Kentucky, respectively—celebrated 
these interventions’ surgical success and the idea that hand transplants under normal levels of 
immunosuppression could be effective for some patients (Dubernard et al., 1998;  Jones et al., 
2000). In these initial case reports, published in the first 6-24 months following surgery, “success” 
in experimental HTX is presented in terms of technical “proof of concept” (the idea that HTX is 
scientifically possible yielding functional returns and extended graft survival) but not in terms of 
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HTX patients’ own understanding of their postoperative wellness and satisfaction with results 
(Dubernard et al., 1998;  Jones et al., 2000). 
Despite the shortcomings of early HTX and VCA outcomes reports, many of these papers 
were cited as showing proof of concept for performing further HTX and for the diversification of 
“composite tissue allotransplantation” (an early name for VCA) to other conditions (Kann and 
Hewitt, 2001; Levi et al., 2003; Wiggins et al., 2004; Ren and Laugel, 2013). For example, HTX 
pioneers Dubernard et al. write in 1999, “We have confirmed the technical feasibility of limb 
transplantation” (Dubernard et al., 1318). HTX clinician researchers in Louisville, Kentucky, 
published similar observations on their own efforts and outcomes: “Our results and those of the 
first human hand transplantation, performed in France, show that early success in hand 
transplantation can be achieved with the use of currently available immunosuppressive drugs” 
(Jones et al., 2000, 472).  
While most of the case studies and review articles published by clinical professionals in 
hand transplantation conclude with some version of the phrase, “hand transplantation is technically 
feasible… and results are encouraging” (Petruzzo et al., 2008, 491), low numbers of patients and 
high variability in treatment protocols have made evidence-based assessment of outcomes difficult 
for clinical researchers, ethicists, and other policymakers and stakeholders. “While these new 
treatments promise the benefit of better esthetic and functional outcomes, they also expose patients 
to new types and degrees of risk, not experienced previously in conventional reconstructive 
treatments,” write VCA providers Barker et al. in 2011. Barker et al. continue: “These risks have 
generated a heated risk versus benefit debate among reconstructive surgeons, bioethicists, the legal 
community, and the popular press, and have greatly influenced the clinical introduction of these 
new treatments” (470). In a similar vein, in the “History and Ethics of Hand Transplants,” HTX 
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clinicians Errico, Metcalfe, and Platt explain why claims made in the early literature on HTX were 
difficult to parse in terms of their “on-the-ground” recommendations for patient candidates and 
providers: 
The experimental nature of this treatment … casts doubt on how informed a 
patient’s decision can truly be. Our experience in the field is only based on a small 
data-set collected over a period of 11 years. The true impact of long-term sequelae 
is not fully understood, and this uncertainty could potentially influence the 
individual’s decision-making process. In addition, the benefits of such a procedure 
could be unintentionally exaggerated by an overzealous physician, motivated by 
the thrill of medical advancement (2012, 4). 
Because as of 2019 fewer than 80 hand transplant surgeries have been performed, providers 
of hand transplantation agree that efforts to evaluate results “objectively” are complicated by the 
impossibility of generating statistically significant analytic insights from case data. In 2004, 
bioethicist Françoise Baylis criticized the thin knowledge base among those deploying “success 
with hand transplants” in arguments supporting new types of VCA interventions: “[These authors] 
do not show unequivocally that hand transplantation is morally acceptable—the fact that 
something is done does not in itself constitute evidence of its moral acceptability … in their haste 
to persuade others … they focus on the technical aspects of [VCA] and issues relevant to the 
research ethics review process” (31). Twenty years after the first speculative discussions of the 
risks and benefits of hand transplantation, the specific nature of the lifestyle and health-related 
tradeoffs for HTX patients, and how these tradeoffs factor into the goal of improving QoL in HTX, 
is not clear.  
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Empirical lacunae in the HTX literature and their ethical import 
Even though lack of available data from HTX case studies is an acknowledged problem 
in the HTX field, there has been little evident interest in collecting and parsing those data that 
can be collected regarding outcomes for hand transplantation, including outcomes data in the 
form of first-person accounts from patients describing their experiences. A worldwide 
collaborative data set on hand transplantation and VCA, the “International Registry on Hand and 
Composite Tissue Allotransplantation” (IRHCTA), endeavors to compile and compare 
outcomes data from HTX/VCA programs around the world. The quantitative and qualitative 
tools used to report VCA outcomes in the IRHCTA are derived from existing assessment 
tools in plastic surgery, hand rehabilitation, and organ transplantation, culled from published 
VCA case studies and review articles or submitted to the Registry by VCA clinician-
researchers on a volunteer basis. The multi-dimensional meaning of hand transplantation as a 
“quality of life improving” operation is represented in the Registry—and in almost all of the 
published case studies and review articles informing the Registry—by measurement-focused 
representations of how well the hand transplant performed on a preselected battery of 
manual and psychosocial activities. Thus, in decontextualized representations of patient 
satisfaction and technical “success,” the lifelong and day-to-day impacts of managed 
complications and the post-transplant lifestyle are not considered. 
Authors of a 2008 report of the IRHCTA describe their efforts to create an 
international record of outcomes in the VCA field as being compromised by the impossibility of 
“analyz[ing] transplantation functional results in a standardized way” (Petruzzo et al., 2008, 
489). The authors go on to characterize the “functional score system” they developed for 
reporting HTX outcomes: “The Hand Transplantation Score System evaluates six aspects [of 
HTX outcomes] for a total of 100 points: Appearance (15 points), Sensibility (20 points), 
Motility (20 points), Psychological and Social acceptance (15 points), Daily activities and Work 
status (15 points), 
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Patient satisfaction and General well-being (15 points)” (Petruzzo et al. 2008,  489-490). 
Although measures for assessing “Psychological and Social acceptance” of hand grafts and for 
“Patient satisfaction and General well-being” are included on this list, a numerical score 
representing recipients’ comprehensive experience of HTX function and side effects does not 
give enough contextual data to inform ethical evaluations of HTX or clinical decision-making in 
ongoing cases. 
The limitations of trying to scientifically depict “success” in HTX makes the writing 
of person-centered ethical guidelines and best practices challenging for stakeholders in the field. 
As Louisville-based bioethicist Paul Simmons wrote in the developmental years of 
hand transplantation: 
How does one assess the impact of taking immunosuppressant drugs the rest of 
one’s life? How does one imagine a life in which undesirable side effects of 
medication becomes routine: the hair loss, the gastrointestinal distress, the diarrhea, 
and the constancy of the regimen? … Knowing the threats to an allotransplant 
recipient is important but not sufficient in the calculus of when to move forward … 
patient perspectives are also vital as risks are weighed against possible benefits 
(2000, 459).  
As Simmons suggests, an evolving, person-oriented bioethics in hand transplantation would take 
on board the challenge of representing quality of life tradeoffs more accurately by attending to the 
aspects of life that HTX patients report as mattering to them. Those providing HTX and those 
providing ethical analysis of HTX need to have accurate data portraying scientific outcomes 
(including metabolic and immunological outcomes data and measurements of hand function using 
standardized tools) in addition to psychosocial outcomes data from patients’ point of view, relevant 
to answering “commonsense” clinical and bioethical questions about the characteristics of a good 
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candidate for HTX and which support activities or cultural context are most likely to return 
successful outcomes. 
Because HTX is focused exclusively on improving QoL of patients, yet these gains are 
attended by significant risks and long-term challenges, HTX patients’ self-reported experiences of 
dis/ability and the ongoing construction of their identity would seemingly be more relevant to 
considering the ethics and value of hand transplantation than decontextualized measurements of 
function or graft health using standardized tools borrowed from cognate fields of healthcare 
(“traditional” organ transplantation for assessing graft health and hand-strength motility 
measurements from hand surgery). The idea that such “scientific” measurements of HTX function 
could be largely immaterial to quality-of-life discussions on hand transplants’ effectiveness has 
not been extensively considered in debates on the ethics and outcomes of in hand transplantation.  
What is “there” in the HTX literature, and what is not 
While there have been some attempts to describe transformations in the health and quality 
of life of HTX patients using self-reported, survey-based methods or thematic analysis of 
psychiatric semi-structured interviews (Bachmann, 2007; Jensen et al., 2012; Kumnig and Jowsey-
Gregoire, 2016), these approaches do not necessarily perform the essential work of representing 
the lived experiences of recipients and their families before and after hand transplant surgery. 
Surveys are useful for eliciting responses from HTX patients on pre-selected criteria regarding 
their observations and experiences, but a weakness of survey research is the need for researchers 
to elicit responses through well-worded, knowledgeable questions, beyond answering which 
respondents do not have ample room for creative self-expression. And, where semi-structured 
psychiatric interviews can illuminate much beyond these measures with regard to patient-
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participants’ self-understanding of their experiences, the unbalanced power structure of psychiatric 
settings may limit patients’ willingness to share the full extent of their observations.    
In a 2012 review titled, “Quality of Life Considerations in Upper Limb Transplantation,” 
Sally E. Jensen and colleagues consulted approximately 250 academic papers on hand 
transplantation to determine QoL effectiveness, of which 27 were included for analysis in their 
study having “quality of life” as the main topic. However, only 3 of these 27 papers included 
interviews with hand graft recipients as part of their methodology. None of the studies was 
conducted using open-ended questioning techniques by non-program-affiliated researchers, and 
none of them quoted patients directly regarding their experiences. In some cases, no attempt was 
made to approach HTX recipients for their point of view even when the stated goals of the research 
were compatible with doing so. In one such study, Slatman and Widdershoven conduct what they 
call a “phenomenological narrative” analysis of the first two hand transplants in Europe. Because 
the authors “were not in a position to collect information from face–to-face interviews,” they 
conducted their analysis using data collected entirely from news media accounts. Slatman and 
Widdershoven acknowledge that in their phenomenology of hand transplantation “empirical 
analysis of embodied self-experience is limited” (2010, 72).  
Hand transplant textbooks seem to make more space than peer-reviewed journal articles 
for patient perspectives. In The Science of Reconstructive Transplantation, (Brandacher, 2015), an 
early chapter featuring exposition on “The Daily Life of a Hand Transplant Recipient” (45) offers 
an account of HTX as told by a patient recipient. The article is written in first person voice and 
details the process of evaluation and recovery, including day-to-day challenges and opportunities 
and general reflections. While it provides some data on the lived experience of the author-patient, 
it is impossible to generalize from this one account, particularly because no explanation is provided 
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regarding the authorial decisions regarding what details are included or editorial decisions about 
why this narrative (or author-patient) was included.  
In a chapter for the textbook, Hand Transplantation, (Lanzetta and Dubernard, 2007), 
Daniele Bachmann writes on the topic of “Quality of Life in Hand Transplant Patients.” Although 
Bachmann did conduct psychiatric interviews with hand transplant recipients, sufficient to yield 
insights on their motivations and experiences, Bachmann’s chapter spans only three pages of the 
400+ page textbook in which it is published. Moreover, it does not offer quotes from patients, and 
does not include long-term retrospective follow-up on how the side effects and complications from 
transplant drugs, and the recovery process, balance against gains of psychosocial considerations 
or manual functionality. In one passage Bachmann alludes to several potential avenues of deep 
concern and interest regarding the post-transplant lives of people with hand grafts:   
[T]ransplantation of hands changes the patient’s body in a radical way; he does not 
get his own hands back (we say “he” because all transplanted patients thus far have 
been men), nor does he return to a previous state. The recipient has to make the 
donor hands his own, and, even with the recovery of motor functions and 
sensitivity, these hands are forever present before the patient’s eyes … The hands 
are also highly charged with meaning in the human being’s imagination: …What, 
for example, did the donor’s hands do before his death, during moments of 
intimacy? The patient’s ability to integrate the transplants is also dependent on the 
reaction of the close family circle, which could display feelings of rejection, of 
disgust or worry, or, on the other hand, could be quite happy for the patient and 
give him vital support in accepting the transplant (2007, 365). 
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Unfortunately, the chapter’s conclusion follows soon after these revelations that transplanted 
hands change the recipient’s own body in “a radical way,” that hand grafts are “highly charged 
with meaning,” and that the patient’s pleasure in owning the hands depends heavily on the 
acceptance of others. Readers can only wonder at the sentiments Bachmann’s patients may have 
expressed that would lead to such compelling statements because the interviews are not published 
alongside professional analysis.  
What is missing and why does it matter? 
“Only time will tell if chronic rejection will preclude the successful long-term outcome of 
the current reconstructive transplants,” write UK plastic surgeons Shehan Hettiaratchy and Peter 
M. Butler in 2003, “…we will have to wait and see if the current immunosuppression based 
procedures herald a new era for transplantation or just another false dawn” (2003, 1226-1227). 
However, despite a flurry of media attention following almost any report of a successful hand 
transplant surgery, meaningful information that would answer the sincere question embedded in 
Hettiaratchy and Butler’s paper—whether hand transplants have brought a “new era” of 
reconstructive options or a “false dawn” for vulnerable patients—has not yet emerged from the 
medical and bioethical literature on hand transplantation. According to UK hand transplant 
surgeons Simon Kay and Daniel Wilks, “Of the large number of [hand and face] transplants 
completed now, outcome data of value is to be found in few,” (2013, 1457, italics added). In 2016 
and 2018, the poor quality of outcomes reporting in the hand transplant field was remarked on by 
HTX practitioners and researchers on healthcare policy and effectiveness in Canada and North 
Carolina (Health Quality Ontario, 2016, 3; Hedges and Rosoff, 2018, 2). Similar observations on 
a lack of useful psychosocial data were published by HTX behavioral health researchers Martin 
Kumnig and colleagues in a 2013 review paper: “Despite a thorough analysis of the literature, the 
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lack of relevant published information in the psychosocial domain of transplanted patients is a 
significant limitation of this overview. The majority of articles do not address the psychosocial 
assessment in any greater than passing detail, so the conclusion that can be made from these highly 
descriptive, mostly empiric studies in the current literature is limited” (425).    
The spectrum of function for hand transplants is broader than for the available alternative 
of bionic and aesthetic prostheses, and includes return of touch sensation, warmth, and “human”-
ness. Nevertheless, hand transplants do not necessarily work better than prosthetics to improve 
their users’ quality of life. While hand transplants and bionic prosthetics both require extensive 
learning and rehabilitation periods before they are useful for even the most basic tasks, many who 
pursue hand transplantation after using bionics emphasize that the work needed to maintain a hand 
graft and the demands of post-care protocols are far more intense than any physical therapy they 
had previously experienced. Additionally, because hand transplants can bring dramatic functional 
returns but are also biological gifts from another person, all functional and psychosocial gains can 
be set back by immunological complications at any point in time. VCA providers J. Rodrigo Diaz-
Siso et al. explain why providers need grounded, up-to-date information on utilization factors in 
hand transplantation: “Because of the associated risks of lifelong immunosuppression, a critical 
responsibility of multidisciplinary vascularized composite allotransplantation teams is to educate 
candidates about the alternative surgical and nonsurgical reconstructive options available to them” 
(2018). Alternatives to HTX must be considered and compared across the full spectrum of known 
potential risks and benefits  (including impact on health, impact on relationships, potential for 
therapeutic return) while keeping in mind that, unlike a prosthetic, a hand transplant is a constant 
lifelong presence on the body both affording and the recipient’s action and movement through the 
world.  
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In an oral history project which informs my dissertation on the “rhetoric of success” in 
hand transplantation (17 interviews total), narrators almost unanimously report experiencing 
functional gains with a hand transplant that were impossible with the prosthetics they had tried 
(Herrington, 2019). However, these gains were made within the parameters of the post-transplant 
lifestyle, including restrictions on diet, activities of daily living, budget and freedom to travel in 
the short or long term. The threat of rejection—which must be constantly monitored and protected 
against—and the specter of life-threatening complications from immunosuppressant drugs attend 
all gains to lifestyle and self-perception following HTX surgery. During rejection, a hand 
transplant can swell, develop spots or lesions, itch, or burn. Therefore, the social and manual 
function of hand grafts decreases during rejections, as the graft(s) might be too swollen or painful 
to use, (and the aesthetic presentation of rejection can be off-putting to others (Herrington, 2019). 
Far from the straightforward, ostensibly objective accounts of outcomes comprising assessments 
of hand transplantation in medical journals, the oral history interviews I collected with hand 
transplant patients and their caregivers paint a much more complex and deeply human picture of 
how “success” is established in hand transplantation (Herrington, 2019; Herrington and Parker, 
2019). How narrators perceived their QoL pre- and post-transplant depended on several factors, 
including whether their personal conception of the value of the HTX process evolved or not with 
their experiences. 
The need for consistent, person-centered outcomes reporting has been emphasized by the 
leading surgical and scientific figures in HTX/VCA—however no strategies have been agreed 
upon for filling empirical gaps. The International Registry is not complete or up to date and lacks 
insights from many programs and patients. Furthermore, patients who have lost their hand grafts 
are not followed at all. Complications, including patient deaths, are not discussed in the academic 
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literature with as much regularity as successful surgeries or milestones. James L. Benedict, an 
ethicist who has studied informed consent issues in HTX/VCA, noted the lack of meaningful 
cooperation towards knowledge generation in hand transplantation and VCA at the 2018 meeting 
of the American Society for Reconstructive Surgery (ASRT) in Chicago:  
“One recognized challenge in the field is a lack of regular data sharing. While the OPTN 
VCA Committee provided a partial remedy to this problem with its requirement for data 
collection and submission for transplants from September 2015 forward, this remedy falls 
far short of international ethical standards for reporting the outcomes of research and 
deprives those in the field, potential patients and the public of critical information. In the 
absence of this information, it is difficult to argue convincingly that the knowledge base, 
skills and systems are in place to consistently produce good to excellent outcomes and that 
the field thus deserves the trust of patients and third-party payers.” 
Even when outcomes of hand transplants are published in a timely fashion and patients followed 
over time, what is typically discussed—e.g.,  manual function (grip strength, etc.) and the clinical 
management of immunosuppression or rejection/infection—is not presented in the frame of asking 
questions about patients’ lived quality of life post-transplant. For instance, commonsense factors 
contributing to HTX patients post-transplant QoL that are not reported in HTX papers—and that 
therefore  cannot be formally shared or even widely known—include the QoL impacts of travel to 
and time spent in the hospital or at (scheduled and unscheduled) medical appointments, the 
intermittent loss of manual and psychosocial function during recovery from infections or 
rejections, and how the long-term (metabolic and immunological) effects of immunosuppression 
on recipients’ health affected HTX patients’ understanding of their quality of life. After 20 years 
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of hand transplantation, we can learn almost nothing about patients’ lives and challenges from the 
literature and even conferences are thin on this aspect.  
So far in this thesis I have introduced HTX and the idea that hand transplants are 
complicated QoL interventions about which knowledge of patient-participants’ lived experience 
is sorely lacking. Below I will develop the argument that—in addition to survey-based self-
assessment of HTX outcomes and analysis of patient interviews conducted in psychiatric or media 
settings—systematic “grounded” qualitative research on HTX patients’ experiences is needed to 
advance bioethical discussions of potential risks and benefits of HTX interventions. Collecting and 
parsing such data may require teams of bioethicists and clinical researchers partnering with 
scholars whose research orientation is toward descriptive or narrative ethnography, medical 
anthropology, social studies of health and medicine, medical oral history, or other methods of 
parsing and authentically portraying lived impacts of medical interventions from the “grounded” 
perspective of patient-participants.  
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2.0 The Ethical Warrant for Integrated Approaches to Assessment of Outcomes in HTX 
and VCA 
Because hand transplantation and VCA are only performed to improve recipients’ quality 
of life, broadening the assessment of “success” to include VCA patients’ self-reported experiences 
of dis/ability and the ongoing construction of their identity would seemingly be appropriate and 
critical for discussion of the ethics and value of reconstructive transplantation. Grounded insights 
from patients’ perspectives must be integrated with standardized “scientific” assessment tools 
(such as tests of kidney function and hand strength-motility, for example) if HTX providers are to 
develop person-centered knowledge of the comparative effectiveness of different research 
protocols and the large-scale impact of these surgeries on patients’ lives—especially because any 
immediate or emerging gains to QoL realized through HTX are attended by significant risks from 
immunosuppression whose serious side effects could disrupt the risk/benefit balance for patient 
families at any time.  
In this second section, I argue that, for those writing about the outcomes and ethics of hand 
transplantation, a more collaborative or “grounded” critical/analytical role may be warranted 
where QoL tradeoffs in HTX are being considered or measured over an extended period of time 
(as they must be to understand these operations’ longitudinal effects). In such situations patients’ 
own words about their experiences can help bioethicists and providers tease out factors relevant to 
ethical analyses of events and ongoing practices in the field, wherein the initially idiosyncratic 
vocabulary of first-person experience can gradually come to replace the (necessarily) less-
contextually specific language of pre-experimental discussions. My call for this type of 
interdisciplinary empirical work is supported by recent theoretical and empirical work by 
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bioethicists and scholars in related fields of research (see especially: Shildrick and Mykitiuk, 2005; 
Newell, 2006; Caenazzo et al., 2017; Svenaeus, 2017; Baylis and Dreger, 2018) 
Because hand transplantation is naturally interdisciplinary, uniting knowledge and 
practices from hand surgery, transplantation, hand rehabilitation, transplant behavioral health, and 
bioethics, the author list for ethics articles in HTX typically includes at least one bioethicist writing 
with clinicians of various specialties. This typical (in HTX bioethics) blend of disciplinary 
perspectives elicited by clinicians and ethicists working together can effectively produce 
discussion of the scientific and analytical tools relevant to parsing the ethicality of HTX/VCA, or 
what outcomes might constitute “success” in a hypothetical frame. However, ethicist-clinician 
partnerships that do not include HTX patients as partners have not been—and will never be—
effective at developing practical knowledge of whether and how HTX can be successful at 
producing QoL benefits for patients (the central driving question of pre-experimental ethics 
debates). As I will show, perspectives from patients, their caregivers, and other workers in the 
daily activities of living with HTX/VCA would substantially improve the relevance and 
productivity of the interdisciplinary ethicist-clinician collaborations that have so far dominated 
debate on HTX outcomes. 
In the early experimental years of hand transplantation, Louisville clinicians Gordon Tobin 
et al. write, “Although the immunologic concerns seemed more formidable to many in the 
beginning, a substantial portion of these issues have been resolved by the immunologic successes 
and graft survivals in the early clinical experience. The ethical issues, however, have emerged as 
sources of ongoing concern” (2005, 1392, italics added). A 2019 paper titled, “Emerging Ethical 
Challenges Raised by the Evolution of Vascularized Composite Allotransplantation,” discusses 
contemporary bioethicists’ response to evolving (rather than diminishing) concerns about the 
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risk/benefit balance in hand transplantation and VCA. An objective of the paper includes 
informing readers about the authors’ efforts towards “developing an ethical framework for the 
future of VCA” (1241). Bioethicist Arthur Caplan and colleagues explain, “Leaders of each 
program performing and/or evaluating VCA in the United States were invited to participate in a 
working group to assess the state and future of VCA ethics and policy. Four meetings were held 
over the course of 1 year to describe key challenges and potential solutions” (1240). Notably for 
Caplan’s group, the removed-from-reality, “expert opinion” of VCA clinicians and bioethicists 
provided the starting point for this ethics initiative—not the grounded experiential knowledge and 
concerns of VCA patient-participants and their families or caregivers. The authors write, 
“Participating members were asked to provide expert opinion and react to drafts of a proposed 
ethical framework … Members met for 4 [workshop-style] sessions … Following the third session, 
discussion points and comprehensive meeting notes from all sessions were compiled and 
synthesized by the NYU/Hopkins leadership team to serve as the starting point for drafting an 
article” (Caplan et al., 2019, 1241).  
 In the authors’ exposition on their process of developing recommendations for hand 
transplantation and VCA ethics, they report having conducted interviews with patients and their 
family caregivers. However, very little information is given about the content of these interviews 
in the working group’s first publication, nor do they illuminate their methods for data collection 
and analysis. Also not described is how the authors generated conclusions based on their exchanges 
with HTX patients (including how many interviews were performed over what period of time, who 
performed the interviews, how long the interviews lasted, whether patients and family members 
were interviewed separately, and whether or not they were interviewed in an institutional or 
public/home context). Although the NYU/Johns Hopkins VCA ethics working group is calling for 
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more systematic research with clear methods of data collection and analysis across the field, they 
do not include methodological details regarding the exchanges with HTX recipients that informed 
their own study, and thus the paper is less informative than it might be. It is ironic that academic 
publications, like this one, arguing for greater attention to patient perspectives in the VCA field 
generally fail to include substantive accounts of patients’ perspectives. The following sentences 
raise concerns about how the evidence of “technical success” in hand transplantation has 
overshadowed collection of evidence the about improvement in QoL of recipients as the actual 
goal of VCA:        
[P]atient-provider relationship challenges are evident throughout the full lifecycle 
of a VCA. Surgeons and teams spend extensive time with VCA recipients in part 
due to the complexity and long-term risks. This may result in unhealthy attention, 
priority, or favoritism of the patient, or a patient having unrealistic expectations of 
the provider … the temporary celebrity status that many VCA patients acquire from 
media coverage, [could also] leave them disappointed and angry with their medical 
team when the media loses interest (Caplan et al., 2018, 1241). 
The framing of key ethical issues in this passage—and in much of the bioethical literature 
regarding HTX—gives preference to the physicians’ point of view. Caplan et al., for example, 
refer to patients’ having “unrealistic expectations of the provider” and seem to overlook the fact 
that the singular goal of a hand transplant surgery is improvement in patient recipients’ quality of 
life. That goal makes central the expectations of the recipient and makes central to candidate 
evaluation and informed consent both the accuracy of the recipient’s understanding and the degree 
of realism of the candidate’s expectations. In another section, the authors write that “despite early 
skepticism, the [HTX/VCA] field has demonstrated feasibility and success” (1240). However, this 
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conclusion is inadequately supported in the absence of empirical studies examining QoL outcomes, 
particularly the subjective and nuanced outcomes that candidates seek. The paper also does not 
show how the working group’s observations are supported through their own critical analysis and 
grounded inquiry of VCA outcomes. The conclusion that the VCA field has demonstrated 
“success” employs a physician/surgeon-centric, medicoscientific-centric notion of “success,” 
which is inadequate for a medical intervention that seeks to improve quality of life as patients 
themselves conceptualize that quality. 
How can bioethicists help the situation in hand transplantation and VCA? 
 The current situation of the ethics of hand transplantation offers an opportunity to consider 
how clinical bioethics can or should work to elevate the perspectives of patients in the HTX field, 
and what types data gathering represent the essential work of producing knowledge on the ethics 
of QoL-enhancing operations. In this thesis I have argued that sparse characterization of HTX 
patients’ pre- and post-transplant QoL in papers reporting outcomes data for HTX is an obstacle 
to knowledge generation and ethical analysis in the field. Systematic efforts to describe and 
understand patients’ lived experiences are needed to ground professional discourse on the 
ethicality of HTX and VCA more generally.  
Even after 20 years of experience in the hand transplant field, low numbers of 
geographically isolated patients make analytic insights on case data impossible. As I argued in 
section 1, there has been an apparent lack of interest among hand transplant professionals—
including bioethicists—in parsing the subjective embodied knowledge of hand transplant patients 
to guide experts’ discussions of HTX ethics in realistic and relevant directions. Such “grounded” 
qualitative research questions are not outside the acceptable and even necessary data-gathering 
activities of HTX clinicians and others who work on these issues. As feminist bioethicist and 
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disability scholar Margit Shildrick and research collaborators on the topic of heart transplantation 
have written, “transplant professionals need to question the limits of what is seen as 
unproblematically therapeutic, and to look beyond conventional data.” Shildrick et al. explain: 
[So-called “raw”] data itself can never be clean and proper. … At the outset of all 
research, choices have already been made about what constitutes necessary and 
sufficient data, what is to be included and excluded, the place and the time frame 
of collection, the methodology employed, and so on. Moreover, rather than the data 
sets of bioscience and social science being in opposition, they may tell a similar 
intersecting story (2017, 53). 
As Shildrick et al., point out, there are no “rules” governing how much doctors and ethicists should 
attend to, rely on, and represent empirical data from their patients’ point of view in published 
reports and even in internal documents.  
Although bioethics discourses regarding hand transplantation have been unclear so far with 
regard to their ability to effectively represent the needs and desires of HTX patients and candidates, 
this need not be the case for the next 20 years of human research in this area. Because there are 
not enough data to make normative statements regarding success of HTX, or the balance of its 
benefits over its burdens, it would seem imperative to engage the work of empirical knowledge 
generation to confirm and augment published outcomes, in order to be able to inform analyses of 
the permissibility of HTX. Those skilled in normative analysis—bioethicists and policy analysts—
should partner with qualitative researchers to develop the body of empirical data necessary to 
address their normative questions and to inform the ethically critical components of HTX itself—
namely, informed consent, candidate evaluation, and provision of support to patients and their 
informal caregivers.  
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Because the rehabilitative potential of hand transplantation can only be realized within the 
constraints of the post-transplant lifestyle, including increased medical surveillance, health risks, 
and potentially burdensome care activities—the ethical impact of HTX must be considered in 
terms of the specific benefits patients felt that they received in the short or long term through their 
participation. Such grounded research questions are not necessarily outside the natural data-
gathering activities of bioethicists, transplant researchers, surgeons, and others who work on these 
issues. Given the deeply person-specific nature of the goals and outcomes in hand transplantation, 
ethical analyses of risks and benefits of HTX would be aided by a “lifeworld-led” approach to 
treating, representing, and conceiving of transplant candidates and recipients.  
As described in paper by philosophers of science and medicine Dahlberg, Todres, and 
Galvin: 
[Lifeworld-led healthcare] … acknowledges differential levels of expertise and 
understanding between patient and professional. The patient can understand her/his 
journey better than any other and in that sense is an expert. Professionals need to 
acknowledge but not relinquish their expertise, and lead their care from an 
expanded view of knowledge as articulated above, and not just from ‘technical’ 
knowledge. This lifeworld knowledge is different from ‘technical’ knowledge, in 
that it is always on the way, whereas technical knowledge is fixed until the next 
new evidence becomes available (2009, 2). 
 For hand transplant patients, the commonsense idea that patients are the experts on their own 
experiences finds particular salience due the inherently risky, deeply personal, 
interpersonally  demanding, lifelong  challenges  of  these  procedures  and  the physical, 
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emotional, and  interpretive  work  HTX  patients  and  their  caregivers  do  to  bring  successful 
outcomes to fruition. 
 In closing this thesis, I argue that ethical analyses of risks and benefits in hand 
transplantation should take into account and indeed give priority to how HTX patients experience 
and weigh the burdens and benefits of HTX. There is need for the systematic collection of data 
regarding this experience, including subjective QoL outcomes, that are more nuanced and personal 
in their robustness than (for instance) the data that are typically included in papers on the HTX 
experience, such as lists of activities of daily living accomplished by patients, quantitative 
functional and sensory measures of graft hands, or descriptions of successfully managed 
complications and measurements of how long grafts persisted on patients’ bodies (see section 1; 
also Herrington 2019 gives an extended critique of the largely unsubstantiated “rhetoric of 
success” and its operations in the HTX field). Given the personal, and frequently socially-mediated 
and identity-related, nature of this experience, it may be said that what is needed is the construction 
of a body of “lifeworld knowledge” that, as Dahlberg, Todres, and Galvin write, “differs from 
‘technical’ knowledge, in that it is always on the way, whereas technical knowledge is fixed until 
the next new evidence becomes available” (Dahlberg et al., 2009, 270).  
The QoL outcomes in HTX are realized by patients and their family members within the 
lifestyle constraints and the ongoing risk-state of transplant patienthood, which lasts as long as a 
hand graft is viable or the rest of the recipients’ life. Clinical interactions that respect this lifeworld 
knowledge respect and integrate the knowledge of both medicoscientific (technical) experts and 
patients, who are expert with regard to their experience and values (Dahlberg et al., 2009, 270). 
Moreover, the decision-making by patient candidates and professionals in the field—during 
candidate evaluation, informed consent, and post-transplant follow-up—should be informed by 
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understanding of not only technical knowledge, but also the lifeworld of HTX recipients. 
Therefore, more data about recipients’ experience and quality of life, both pre- and post-HTX, and 
about their experience with the processes of candidate evaluation and informed consent, need to 
be collected and used both to ground ethical analysis of HTX and to inform the processes of 
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